Fig. 3From: Evaluation of major mite allergens from European standardized commercial extracts for in vivo diagnosis: addressing the need for precision medicineCAP inhibition of commercial extracts (B. tropicalis and D. pteronyssinus) from manufacturers 1 to 9Back to article page